Cerebrospinal fluid monoclonal antibodies detect cancer cells

Malignant cells in cerebrospinal fluid include cancer cells, neuroectodermal tumor cells and lymphoma cells. The positive rate can reach 60%. Monoclonal antibody technology can identify the tissue source of malignant cells and help early diagnosis of cancerous meningeal disease.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.